Focus Partners Advisor Solutions’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$306K Sell
1,054
-2,634
-71% -$866K ﹤0.01% 967
2025
Q4
$1.29M Buy
3,688
+278
+8% +$93.9K 0.02% 425
2025
Q3
$1.05M Buy
3,410
+2,109
+162% +$656K 0.01% 500
2025
Q2
$504K Sell
1,301
-1,311
-50% -$527K 0.01% 669
2025
Q1
$1.14M Buy
2,612
+1,756
+205% +$705K 0.02% 348
2024
Q4
$316K Sell
856
-351
-29% -$147K 0.01% 593
2024
Q3
$628K Buy
1,207
+345
+40% +$184K 0.01% 392
2024
Q2
$467K Buy
862
+198
+30% +$105K 0.01% 387
2024
Q1
$345K Buy
+664
New +$330K 0.01% 429
2023
Q1
Sell
-414
Closed -$213K 365
2022
Q4
$213K Sell
414
-369
-47% -$187K 0.02% 314
2022
Q3
$356K Buy
783
+126
+19% +$60.3K 0.02% 272
2022
Q2
$318K Buy
657
+84
+15% +$41.6K 0.03% 250
2022
Q1
$281K Buy
+573
New +$262K 0.03% 255

Other funds holding ELV

Focus Partners Advisor Solutions's ELV Position: Q1 2026 in Review

Focus Partners Advisor Solutions reduced its Elevance Health (ELV) stake by 71% in Q1 2026, selling an estimated $866K and leaving 1,054 shares worth $306K. The position accounts for ﹤0.01% of the portfolio, ranked #967.

Focus Partners Advisor Solutions first reported a position in ELV in Q1 2022 and has held it in 13 quarters since. The position peaked at $1.29M in Q4 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Focus Partners Advisor Solutions held 1,054 shares of Elevance Health worth $306K as of Q1 2026.
  • Focus Partners Advisor Solutions sold 2,634 Elevance Health shares in Q1 2026, an estimated $866K.
  • Elevance Health made up ﹤0.01% of Focus Partners Advisor Solutions's portfolio in Q1 2026, its #967 holding.
  • Focus Partners Advisor Solutions first reported a position in Elevance Health in Q1 2022 and has held it in 13 quarters since.
  • Focus Partners Advisor Solutions's Elevance Health position peaked at $1.29M in Q4 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Focus Partners Advisor Solutions's 13F filing for Q1 2026, filed 13 May 2026.